A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Florida
Hospital Universitari de Bellvitge
Peking University People's Hospital
New Mexico Cancer Research Alliance
M.D. Anderson Cancer Center
Hackensack Meridian Health
Northwestern University
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
City of Hope Medical Center
Peking Union Medical College Hospital
Uruk University
National Cancer Institute (NCI)
Medical University of Silesia
M.D. Anderson Cancer Center
Fudan University
Fudan University
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Tongji Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Peking University People's Hospital
Peking University People's Hospital
Tufts Medical Center
WellSpan Health
Region Stockholm
Imperial College London
Queensland Centre for Gynaecological Cancer
Federico II University
Imperial College Healthcare NHS Trust
Peking University People's Hospital
Women's Hospital School Of Medicine Zhejiang University
GOG Foundation
Royal College of Surgeons, Ireland
Zonguldak Bulent Ecevit University
Beijing Obstetrics and Gynecology Hospital
Hasanuddin University
Pirogov Russian National Research Medical University
Peking University People's Hospital
University of Campania Luigi Vanvitelli
Regina Elena Cancer Institute
University of Campania Luigi Vanvitelli
Sohag University
Assiut University
Sohag University
Vancouver Coastal Health Research Institute
West China Second University Hospital